An oral liquid version of the generic epilepsy drug clobazam has been launched in the UK.
Tapclob is available in two presentations, one of 5mg/5ml and one of 10mg/5ml. It is an off-white oral solution presented in a 150ml glass bottle.
The product, manufactured by Martindale Pharma, is the first licensed oral liquid suspension version of clobazam and has the same indications as clobazam tablets.
It will be used principally as an adjunctive therapy for epilepsy, with the majority of use believed to be in children, according to its manufacturer.
Are you able to Speak Out Safely? Sign our petition to put pressure on your trust to support an open and transparent NHS.